BridgeBio Pharma reported revenue of $243.68M and net income of -$155.89M for the quarter ended Jun 2026, up 120.4% year over year. This income statement covers 33 quarters of results from Jun 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||||||||||||||||||
| Revenue | 2.34M | 10.00M | 1.69M | 73.75M | 0.34M | 1.87M | 1.83M | 1.64M | 4.09M | 1.75M | 211.12M | 2.17M | 2.73M | 5.88M | 116.63M | 110.56M | 120.70M | 154.18M | 194.51M | 243.68M | |||||||||||||
| Cost of RevenueCost of Rev | 1.45M | 1.55M | 1.35M | 0.70M | 0.74M | 0.65M | 0.65M | 0.60M | 0.60M | 0.60M | 0.60M | 0.60M | 0.60M | 2.08M | 2.64M | 3.65M | 6.56M | 8.11M | 9.94M | 15.05M | |||||||||||||
| Gross Profit | 0.89M | 8.45M | 0.35M | 73.05M | -0.40M | 1.22M | 1.18M | 1.04M | 3.49M | 1.15M | 210.52M | 1.57M | 2.13M | 3.80M | 113.99M | 106.91M | 114.14M | 146.07M | 184.58M | 228.63M | |||||||||||||
| Operating items | |||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 104.31M | 122.20M | 107.65M | 108.40M | 92.51M | 90.90M | 92.86M | 107.49M | 125.14M | 130.23M | 140.97M | 114.69M | 120.44M | 130.35M | 111.43M | 111.23M | 112.87M | 116.42M | 126.64M | 149.45M | |||||||||||||
| Selling, General & AdministrativeSG&A | 46.08M | 54.75M | 43.71M | 36.43M | 31.19M | 31.86M | 31.11M | 36.12M | 35.78M | 47.58M | 65.81M | 59.52M | 68.82M | 94.78M | 106.36M | 129.15M | 137.62M | 158.09M | 163.90M | 186.26M | |||||||||||||
| Restructuring CostsRestructuring | 22.66M | 8.40M | 5.02M | 7.69M | 3.37M | 3.53M | 0.27M | 0.75M | 3.40M | 2.89M | 4.62M | 4.69M | 0.57M | 0.81M | 8.84M | 11.13M | |||||||||||||||||
| Other Operating ExpensesOther Opex | 1.45M | 1.55M | 1.35M | 0.70M | 0.74M | 0.65M | 0.65M | 0.60M | 0.60M | 0.60M | 0.60M | 0.60M | 0.60M | 2.08M | 2.64M | 3.65M | 6.56M | 8.11M | 9.94M | 15.05M | |||||||||||||
| Operating ExpensesOpex | 151.84M | 178.50M | 175.37M | 153.92M | 129.45M | 131.10M | 127.99M | 147.74M | 161.78M | 179.16M | 210.78M | 177.71M | 194.48M | 231.91M | 221.00M | 244.84M | 265.90M | 293.74M | 300.47M | 350.75M | |||||||||||||
| Operating IncomeOp. Inc | -149.50M | -165.61M | -173.68M | -80.18M | -129.12M | -129.23M | -126.16M | -146.10M | -157.69M | -177.42M | 0.34M | -175.54M | -191.75M | -226.03M | -104.37M | -134.28M | -145.20M | -139.56M | -105.96M | -107.08M | |||||||||||||
| EBIT | -149.50M | -165.61M | -173.68M | -80.18M | -129.12M | -129.23M | -126.16M | -146.10M | -157.69M | -177.42M | 0.34M | -175.54M | -191.75M | -226.03M | -104.37M | -134.28M | -145.20M | -139.56M | -105.96M | -107.08M | |||||||||||||
| Non-operating items | |||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 11.07M | 15.13M | 20.34M | 20.28M | 19.82M | 19.99M | 20.12M | 20.59M | 20.31M | 20.27M | 23.47M | 22.94M | 23.06M | 21.52M | 18.12M | 11.61M | 11.74M | 11.64M | 12.94M | 13.28M | |||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.23M | 0.18M | -0.25M | -0.04M | 2.42M | 4.09M | 0.32M | 0.07M | 3.79M | 5.58M | -0.03M | -0.01M | 3.30M | 4.68M | -0.01M | 3.90M | 6.24M | 4.33M | -0.02M | 6.66M | |||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | -0.68M | 28.28M | -7.58M | -10.82M | 6.33M | 4.56M | -0.60M | 1.48M | -5.28M | 21.78M | -26.59M | 126.29M | 52.03M | -21.16M | 6.55M | 16.46M | 11.82M | 4.25M | 5.59M | ||||||||||||||
| Non Operating IncomeNon Op. Inc. | -11.52M | 13.33M | -27.65M | 77.62M | -11.08M | -11.34M | -16.57M | -14.60M | -21.80M | 7.09M | -36.50M | 100.00M | 27.50M | -40.21M | -65.24M | -47.38M | -41.28M | -55.19M | -60.60M | -48.81M | |||||||||||||
| Net income details | |||||||||||||||||||||||||||||||||
| EBT | -160.33M | -180.57M | -194.27M | -100.50M | -146.52M | -145.13M | -145.97M | -166.62M | -174.21M | -192.11M | -23.16M | -75.54M | -164.25M | -266.24M | -122.50M | -181.66M | -186.48M | -194.75M | -118.92M | -155.89M | |||||||||||||
| Tax ProvisionsTaxes | 1.15M | 2.10M | -1.54M | -0.17M | |||||||||||||||||||||||||||||
| Profit After TaxPAT | -161.02M | -152.28M | -201.33M | -2.56M | -140.19M | -140.57M | -142.73M | -160.70M | -179.49M | -170.33M | -36.16M | -75.54M | -164.25M | -267.39M | -169.61M | -183.76M | -184.94M | -194.63M | -166.56M | -155.89M | |||||||||||||
| Equity Income | -7.92M | -13.10M | -22.70M | -15.56M | -20.19M | -15.83M | -21.03M | -18.28M | -6.43M | ||||||||||||||||||||||||
| Income from Non-Controlling InterestsInc. Minority | -5.08M | -5.11M | -4.93M | 7.30M | -2.85M | -2.98M | -2.58M | -2.80M | -2.49M | -2.18M | -0.94M | -2.09M | -2.21M | -2.34M | -2.19M | -1.85M | -2.19M | -1.77M | -2.51M | -3.67M | |||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -160.33M | -180.57M | -194.27M | -100.50M | -146.52M | -145.13M | -145.97M | -166.62M | -174.21M | -192.11M | -23.16M | -75.54M | -164.25M | -267.39M | -122.50M | -183.76M | -184.94M | -194.59M | -118.92M | -155.89M | |||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -160.33M | -180.57M | -194.27M | -100.50M | -146.52M | -145.13M | -145.97M | -166.62M | -174.21M | -192.11M | -23.16M | -75.54M | -164.25M | -267.39M | -122.50M | -183.76M | -184.94M | -194.59M | -118.92M | -155.89M | |||||||||||||
| Income towards Parent CompanyParent Net Inc | -160.33M | -180.57M | -194.27M | -100.50M | -146.52M | -145.13M | -145.97M | -166.62M | -174.21M | -192.11M | -23.16M | -75.54M | -164.25M | -267.39M | -122.50M | -183.76M | -184.94M | -194.59M | -118.92M | -155.89M | |||||||||||||
| Net Income towards Common StockholdersNet Income | -155.94M | -147.18M | -196.40M | -9.86M | -137.34M | -137.59M | -140.16M | -157.90M | -177.00M | -168.15M | -35.22M | -73.46M | -162.04M | -265.05M | -167.42M | -181.90M | -182.74M | -192.86M | -164.04M | -152.22M | |||||||||||||
| Additional items | |||||||||||||||||||||||||||||||||
| EPS (Basic) | -1.06 | -1.02 | -1.35 | -0.07 | -0.93 | -0.93 | -0.92 | -0.98 | -1.08 | -1.03 | -0.20 | -0.39 | -0.86 | -1.42 | -0.88 | -0.95 | -0.95 | -1.01 | -0.84 | -0.78 | |||||||||||||
| EPS (Diluted) | -1.06 | -1.02 | -1.35 | -0.07 | -0.93 | -0.93 | -0.92 | -0.98 | -1.08 | -1.03 | -0.20 | -0.39 | -0.86 | -1.42 | -0.88 | -0.95 | -0.95 | -1.01 | -0.84 | -0.78 | |||||||||||||
| Shares Outstanding | 146.66M | 144.36M | 145.88M | 146.68M | 147.94M | 147.47M | 152.65M | 160.54M | 163.31M | 162.79M | 178.71M | 187.59M | 188.51M | 186.08M | 190.15M | 190.52M | 191.85M | 191.53M | 194.79M | 195.79M | |||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 146.66M | 144.36M | 145.88M | 146.68M | 147.94M | 147.47M | 152.65M | 160.54M | 163.31M | 162.79M | 178.71M | 187.59M | 188.51M | 186.08M | 190.15M | 190.52M | 191.85M | 191.53M | 194.79M | 195.79M | |||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 147.09M | 147.34M | 147.69M | 148.24M | 149.37M | 150.63M | 160.44M | 161.42M | 174.13M | 175.08M | 187.12M | 188.03M | 188.99M | 190.04M | 189.83M | 191.16M | 192.63M | 194.77M | 195.71M | 195.28M | |||||||||||||
| EBITDA | -149.50M | -165.61M | -173.68M | -80.18M | -129.12M | -129.23M | -126.16M | -146.10M | -157.69M | -177.42M | 0.34M | -175.54M | -191.75M | -226.03M | -104.37M | -134.28M | -145.20M | -139.56M | -105.96M | -107.08M | |||||||||||||
| Interest ExpensesInt Expense | 11.07M | 15.13M | 20.34M | 20.28M | 19.82M | 19.99M | 20.12M | 20.59M | 20.31M | 20.27M | 23.47M | 22.94M | 23.06M | 21.52M | 18.12M | 11.61M | 11.74M | 11.64M | 12.94M | 13.28M | |||||||||||||
| Tax Rate | -0.43% | -1.16% | 0.83% | 0.08% |